India Globalization Capital Competitors and Similar CompaniesClear all
India Globalization Capital's competitors and similar companies include Hemogenyx Pharmaceuticals.
 India Globalization Capital India Globalization Capital develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States. |  Hemogenyx Pharmaceuticals Hemogenyx Pharmaceuticals, formerly Silver Falcon, is a pre-clinical stage biopharmaceutical company. | |
Founding Date | Founding Date 2005 | Founding Date 2013 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Bethesda, US HQ | Locations London, GB HQ |
Employees | Employees 50150% increase | Employees 16 |
Valuation ($) | Valuation ($) 30 m | Valuation ($) 23.1 m |
Financial | ||
Revenue (est.) | Revenue (est.) $869k (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $572k (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $297k (FY, 2025) | Gross profit £7k (FY, 2025) |
Net income | Net income ($4.1m) (FY, 2025) | Net income (£9.8m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Hemogenyx Pharmaceuticals
HQ
London, GB
Employees
16
Hemogenyx Pharmaceuticals, formerly Silver Falcon, is a pre-clinical stage biopharmaceutical company.
View company